Terug naar overzicht

YES!Delft en UtrechtInc bij internationale top universitaire bedrijfsincubators

World Top Business Incubator

This year, UBI global defined 4 categories. YES!Delft and UtrechtInc were respectively ranked 2 and 10 in the category: World Top Business Incubator – Affiliated with University. In 2015 YES!Delft ranked 9th on the global list.

This result proves that our programs really are of world class. With our Discovery Track, Validation Lab and Accelerator program we help startups grow successfully within 9 months from business idea to investor-ready.
~ EJ Lugt, Managing Director at YES!Delft


UtrechtInc also maintains a top position on the international international list by UBI Global and is glad to receive this recognition. Managing Director Jorg Kop: “We offer supporting programs to researchers of Utrecht University and UMC Utrecht to bring research to the market. This way, we contribute to the valorization of scientific knowledge and making this publicly accessible.” Since 2009 the incubator supported 184 startups.


Startup Envoy Prince Constantijn at StartupDelta congratulates YES!Delft and UtrechtInc. “Incubators and accelerators can play a crucial role in the valorization of scientific data and supporting academic startups. The universities of Delft and Utrecht must be proud of the successes of YES!Delft and UtrechtInc, who are contributing immensely to the Dutch startup and scale-up ecosystem.”


Every two years UBI Global, a renowned Swedish research- and advicebureau in the field of business incubation, conducts research amongst 500 incubators and accelerators in over 70 countries. An example of a selection criteria are the accessibility to capital and economic impact of the incubators. In 2016, the 259 participating programs supported over 10.000 startups in total, research shows. The total number of employees was 72.000. In the past 5 years, the startups raised a total of 4,7 billion euros and had a total of 3,2 billion in revenue.

The ranking list was announced at the World Incubation Summit in Toronto (CAN). Curious for the entire global ranking? Please visit www.ubi-global.com.


Source / YES!Delft


Terug naar overzicht

Slimme parkeeroplossing ParkBee wint Internationale vastgoed innovatie competitie

The round is led by German-based Statkraft Ventures, with participation from existing investors such as InnovationQuarter. Statkraft Ventures is backed by the Statkraft Group, which claims to be Europe’s largest generator of renewable energy.

Originally launched in Amsterdam in early 2016 where it now has over 60 parking locations, ParkBee says the new capital will be used for further U.K. expansion after the burgeoning company recently brought its offering to London. It already has over 20 private car parks using the startup’s wares in the U.K. capital city.

Specifically, this consists of hardware ParkBee had to develop that is retrofitted to a private car park’s existing barrier or security system. Then there is a cloud platform that controls the bookings and unlocking of spaces and lets the car park owner handle inventory management.

The whole thing is also integrated with consumer-facing car parking space booking apps RingGo and Parkmobile, which let you unlock your booked space.

Parking is an enormous hassle in every large city, and streets are only getting fuller, whilst the parking capacity is there but not yet accessible for the general public. – ParkBee commercial director Wouter de Bruijne.

“It’s hard to believe that there are so many unused parking spaces in London, Amsterdam and almost any large city. The car parks of office buildings, apartment buildings but also hotels, business centres or sport venues have a lot of capacity, usually secure behind a closed speed gate or barrier. ParkBee opens up these locations to the public”.

Furthermore, de Bruijne argues there is major upside for landlords and other private car park owners with underutilized inventory. “The real-estate sector is always looking for ways to optimise the use of space. We optimise the use of their buildings and provide an additional revenue stream, he says.

To that end, the list of private property companies ParkBee is already working with include JLL, BT and local councils in the U.K.

Meanwhile, the ParkBee business model is straightforward. The company shares revenue generated through hiring out each parking space with the owner or at a larger location it rents the parking spots directly from the owner, therefore taking on a little more risk. In addition, the startup splits the fee it charges consumers with RingGo or Parkmobile.

Source / TechCrunch

Terug naar overzicht


Ready for a growth spurt

McNetiq, founded in 2014, offers the patented and award-winning Controlock technology. This magnet application is the most secure, cost-efficient, durable and flexible temporary steel connection without the use of (temporary) welds. The Controlock is the first magnet that can be tested and used on different surfaces. It offers considerable advantages compared to traditional steel connections, such as drilling and welding.

With this investment, we can further strengthen our organisation and give the product development a powerful boost. – Willem van der Graaf, McNetiq

McNetiq is ready to launch their product on a larger scale. Participation in the World Port Accelerator PortXL in 2017 contributed to the acceleration of the development and professionalisation of the company and was followed by the entry of the Rotterdam Port Fund.

Boosting product development

The company McNetiq fits the investment profile of the Rotterdam Port Fund. “The potential of the Controlock technology has been proven and extensively tested,” says Frans van der Harst of the Rotterdam Port Fund. “We are excited to support the company in their ambition to apply the technology internationally to many new products to be developed, in different market segments.”

“We are very happy with our new partners,” says director Willem van der Graaf of McNetiq. “With this investment, we can further strengthen our organisation and give the product development a powerful boost. It’s also nice to see that the innovation ecosystem works in Rotterdam.”

“We have been in touch with McNetiq for a long time and see enormous potential in this technology. It’s fantastic to see that the company will make a growth spurt with this investment.  We will support the company’s growth from our wide range of activities.” Says Francis Quint, Head of Capital at InnovationQuarter.

The Rotterdam Port Fund is an independent investment fund that invest in innovative companies with in port-related activities with attractive market prospects. The fund is an initiative of the Port of Rotterdam Authority, NIBC Bank, InnovationQuarter, Koninklijke Doeksen and the Rotterdam entrepreneurs Peter Goedvolk and Luc Braams.

New management

McNetiq’s innovative Controlock magnetic anchors enable cost-effective and safe performance of maintenance and repair work in steel environments. The magnetic anchor points are used in a variety of markets, including for scaffolding in the offshore petrochemical and maritime industry.

With the investment of the Fund, the composition of the management team will change. It will consist of Willem van der Graaf (CEO), founder Edwin van der Heide (CCO) and founder Bas Gravendeel (CTO/CRO).

Terug naar overzicht

Concor Neonatal ontvangt startkapitaal voor te vroeg geboren babys_01-980x450px

Benefits of not immediately cutting the umbilical cord

In the Netherlands, approximately 12,000 children are born prematurely every year, more than 30 a day. Children born prematurely have a greater risk of permanent physical and mental complications.

We are very happy with this capital injection from UNIIQ, which will enable us to take an important step in ensuring that millions of babies born prematurely each year can receive improved care – Rianne Rotink,  CEO Concord Neonatal

The advantages of waiting several minutes before cutting the umbilical cord, or ‘delayed cord clamping’, have been recognised worldwide, not least because it affords higher chances of survival and less risk of complications. Unfortunately, babies that need urgent care are currently unable to reap the benefits of delayed cord clamping. In order to take them to a separate resuscitation table, the doctor must cut the umbilical cord immediately. To solve this problem, neonatologist Dr Arjan te Pas of Leiden University Medical Center (LUMC) has developed Concord: “Waiting to clamp the umbilical cord until the infant is breathing properly ensures a better blood flow in the vulnerable new born baby”, explains Te Pas.

Concord keeps baby close to mother

Concord is an innovative delivery table that can be used for all births, both in delivery rooms and for caesarean sections in operating theatres. Immediately after birth, the baby can be placed on the bed, which is  positioned over the mother so that the umbilical cord can remain connected. Besides the advantage of better blood flow, the baby can stay close to its mother, allowing for instant bonding with her new born baby.

Concor Neonatal ontvangt startkapitaal voor te vroeg geboren babys_02-980x450px

Concord improves care in the first few critical minutes

To enable clinical research in various international hospitals and to market Concord worldwide, NLC – The Healthtech Venture Builder – founded the start-up Concord Neonatal BV. With UNIIQ’s investment, Concord Neonatal can develop the current prototype into a CE‑certified product and market it.

CEO Rianne Rotink explains: “Concord is a fantastic invention that can have a huge impact on the lives of these vulnerable babies and their families. We are very happy with this capital injection from UNIIQ, which will enable us to take an important step in ensuring that millions of babies born prematurely each year can receive improved care.”

“UNIIQ investments are focused on both the technical and market validation of a technology”, says Liduina Hammer, UNIIQ fund manager. “The developments planned at Concord fit seamlessly with our focus. It is a promising life-saving technology that could have a major impact on the care of premature babies in the future.”

Terug naar overzicht

The Interreg project “Codexs4SMEs”

Although personalised medicine promises healthcare savings by delivering the right dose of the right drug to the right patient at the right time, the use of companion diagnostics is essential if it is to achieve the optimum effect. North-Western Europe is lagging far behind the USA in this field, with a current figure of just 1% for companion diagnostic tests in Germany. The Interreg project Codex4SMEs (Companion Diagnostics expedited for small and medium-sized enterprises) is looking to change this. The network of nine partners and two subpartners from seven different countries is aiming to promote the development of companion diagnostics along the entire SME added-value chain. The partners met for the kick-off event in Stuttgart to get the project off to a successful start.

A first meeting

The first day of the meeting was intended exclusively for project partners and focused on developing a communication strategy for Codex4SMEs.
The unofficial part of the event continued on the morning of the second day, when the participants discussed implementation of the various Codex4SMEs work packages and initial activities such as organising regional roadshows for all project partners. The aim here is to get an idea of the “ecosystem” – that is to say all companies in the region who are playing an active role in companion diagnostics.
Performing a gap analysis, which electronically records companies involved in the value-added chain for developing these diagnostics, is another important initial aspect of Codex4SMEs.

The kick-off event including keynotes

Along with the keynote speakers, several SMEs were also invited to the lunch that kicked off the official part of the event. The presentations by Dr. Dirk Biskup from CeGaT GmbH in Tübingen and Dr. Thomas Theisen from TÜV Süd Product Service GmbH in Munich met with great interest. Biskup explained the role of personalised medicine and the contribution companion diagnostics can make to this. He believes a rethink is called for. With tumour diseases in particular, for example, genetic diagnostics should help select the optimum patient treatment in the context of molecular tumour boards. In this connection, Biskup suggests a broader interpretation of companion diagnostics, which he feels should not be restricted to deciding for or against a particular medicine but should contribute fully to identifying the best possible treatment for the patient concerned.
The take-home message of Theisen’s presentation was to act NOW in addressing the EU’s new In Vitro Diagnostics Regulation (IVDR). “This means analysing your product portfolio and tackling significant changes resulting from the IVDR,” he says.

With just 18 people in attendance, the event was relatively small but benefited from high-profile speakers and committed participants.

Codex4SMEs - Companion Diagnostics expedited for SMEs